P

Inventor

LIVERMORE DAVID

GB10 patents
⚠️ This page may combine multiple inventors who share the name “LIVERMORE DAVID”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

TAKEDA PHARMACEUTICALS CO

5 patents
US11129828B2Sep 28, 2021

Pyridazinone compounds and their use as DAAO inhibitors

TAKEDA PHARMACEUTICALS CO1 citations71
US10463663B2Nov 5, 2019

Pyridazinone compounds and their use as DAAO inhibitors

TAKEDA PHARMACEUTICALS CO1 citations71
US12186313B2Jan 7, 2025

Pyridazinone compounds and their use as DAAO inhibitors

TAKEDA PHARMACEUTICALS CO0 citations60
US9750748B2Sep 5, 2017

Pyridazinones as DAAO enzyme inhibitors

TAKEDA PHARMACEUTICALS CO1 citations50
US10287286B2May 14, 2019

Compounds

TAKEDA PHARMACEUTICALS CO0 citations37

HEPTARES THERAPEUTICS LTD

2 patents
US9593106B2Mar 14, 2017

Piperidin-1-yl and azepin-1-yl carboxylates as muscarinic M4 receptor agonists

HEPTARES THERAPEUTICS LTD20 citations89
US10030012B2Jul 24, 2018

Piperidin-1-yl and azepin-1-yl carboxylates as muscarinic M4 receptor agonists

HEPTARES THERAPEUTICS LTD9 citations81

FARNABY WILLIAM

2 patents
US9290456B2Mar 22, 2016

Pyridazinone compounds and their use as DAAO inhibitors

FARNABY WILLIAM4 citations80
US9180122B2Nov 10, 2015

5- or 6-substituted 3-hydroxy-2 (1 H)-pyridinones as D-amino acid oxidase (DAAO) inhibitors in therapy of diseases such as schizophrenia, cognitive disorder and pain

FARNABY WILLIAM6 citations69

TAKEDA PHARMACUETICAL COMPANY LTD

1 patent
US9931340B2Apr 3, 2018

Pyridazinone compounds and their use as DAAO inhibitors

TAKEDA PHARMACUETICAL COMPANY LTD4 citations77